Literature DB >> 1079717

Peroneal nerve stimulator in rehabilitation of hemiplegic patients.

K Takebe, C Kukulka, M G Narayan, M Milner, J V Basmajian.   

Abstract

Of nine hemiplegic patients having foot-drop who were test-treated with the Philips functional electronic peroneal stimulator, only three who tolerated continued use of the stimulator for five weeks had improvement in function. Findings in these cases indicate that to be selected for trial use of a stimulator a hemiplegic patient should fulfill the following criteria: (1) be in the hospital, (2) be ambulant with or without a cane and/or short leg brace, (3) have no severe contracture of the ankle joint, (4) have no severe spasticity, (5) have no obvious lower motor neuron lesions, (6) be cooperative and intelligent, (7) have no severe manual difficulty (he should be able to put on the stimulator without assistance), and (8) be able to tolerate the discomfort from the stimulation.

Entities:  

Mesh:

Year:  1975        PMID: 1079717

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  4 in total

1.  Modified implanted drop foot stimulator system with graphical user interface for customised stimulation pulse-width profiles.

Authors:  T O'Halloran; M Haugland; G M Lyons; T Sinkjaer
Journal:  Med Biol Eng Comput       Date:  2003-11       Impact factor: 2.602

2.  Effects of waveform parameters on comfort during transcutaneous neuromuscular electrical stimulation.

Authors:  B R Bowman; L L Baker
Journal:  Ann Biomed Eng       Date:  1985       Impact factor: 3.934

3.  Therapeutic effects of functional electrical stimulation of extremities.

Authors:  L Vodovnik
Journal:  Med Biol Eng Comput       Date:  1981-07       Impact factor: 2.602

4.  Long-term outcomes of semi-implantable functional electrical stimulation for central drop foot.

Authors:  Lars Buentjen; Andreas Kupsch; Imke Galazky; Roman Frantsev; Hans-Jochen Heinze; Jürgen Voges; Janet Hausmann; Catherine M Sweeney-Reed
Journal:  J Neuroeng Rehabil       Date:  2019-06-11       Impact factor: 4.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.